Atopic Dermatitis Upcoming Therapies

View All

Atopic dermatitis market
Atopic dermatitis market and a Dupilumab dominance

Dupilumab, a monoclonal antibody, is administered in the form of injection for the treatment of Atopic dermatitis (Eczema) in adults and children of age 12 and old. The injection works by hampering the substance in the body, which produces allergic reactions. Dupilumab is a receptor-antagonist and binds to the alph...

Find More